{"log_id": 7099450267817188893, "direction": 0, "words_result_num": 74, "words_result": [{"probability": {"variance": 0.001692, "average": 0.989041, "min": 0.755493}, "location": {"width": 699, "top": 79, "height": 44, "left": 123}, "words": "【孕妇及哺乳期妇女用药】1.利福平可透过胎盘,动物实验曾引起畸胎。人类"}, {"probability": {"variance": 6.6e-05, "average": 0.99651, "min": 0.962463}, "location": {"width": 744, "top": 103, "height": 42, "left": 78}, "words": "虽尚无致畸报道,但目前无足够资料表明可在妊娠期安全应用。3个月以内孕妇禁"}, {"probability": {"variance": 0.000718, "average": 0.991804, "min": 0.846636}, "location": {"width": 747, "top": 126, "height": 43, "left": 79}, "words": "用。3个月以上孕妇慎用。2.利福平可由乳汁排泄,哺乳期妇女用药应充分权衡利"}, {"probability": {"variance": 0, "average": 0.999738, "min": 0.999318}, "location": {"width": 171, "top": 161, "height": 28, "left": 79}, "words": "弊后决定是否用药"}, {"probability": {"variance": 7e-06, "average": 0.998358, "min": 0.98614}, "location": {"width": 606, "top": 174, "height": 39, "left": 136}, "words": "儿童用药】本品在5岁以下小儿应用的安全性尚未确立。婴儿慎用"}, {"probability": {"variance": 4.6e-05, "average": 0.997432, "min": 0.966722}, "location": {"width": 479, "top": 199, "height": 39, "left": 135}, "words": "老年用药】老年患者肝功能有所减退,用药量应酌减"}, {"probability": {"variance": 0.000129, "average": 0.996, "min": 0.936258}, "location": {"width": 690, "top": 219, "height": 41, "left": 134}, "words": "药物相互作用】1.饮酒可致利福平性肝毒性发生率增加,并增加利福平的代"}, {"probability": {"variance": 0.00051, "average": 0.993836, "min": 0.865442}, "location": {"width": 745, "top": 242, "height": 41, "left": 79}, "words": "谢,需调整利福平剂量,并密切观察患者有无肝毒性出现。2.对氨基水杨酸盐可影"}, {"probability": {"variance": 3e-06, "average": 0.998901, "min": 0.992313}, "location": {"width": 745, "top": 266, "height": 39, "left": 82}, "words": "响本品的吸收,导致其血药浓度减低;如必须联合应用时,两者服用间隔至少6小"}, {"probability": {"variance": 0.001328, "average": 0.990437, "min": 0.776636}, "location": {"width": 745, "top": 287, "height": 42, "left": 80}, "words": "时。3.本品与异烟肼合用肝毒性发生危险增加,尤其是原有肝功能损害者和异烟肼"}, {"probability": {"variance": 1e-06, "average": 0.999147, "min": 0.996553}, "location": {"width": 125, "top": 326, "height": 22, "left": 82}, "words": "快乙酰化患者"}, {"probability": {"variance": 0.000115, "average": 0.996346, "min": 0.942478}, "location": {"width": 575, "top": 310, "height": 37, "left": 248}, "words": "利福平与乙硫异烟胺合用可加重其不良反应。5.氯苯酚嗪可减少"}, {"probability": {"variance": 4e-05, "average": 0.997817, "min": 0.962583}, "location": {"width": 743, "top": 334, "height": 39, "left": 83}, "words": "利福平的吸收,达峰时间延迟且半衰期延长。6.利福平与咪康唑或酮康唑合用,可"}, {"probability": {"variance": 0.001204, "average": 0.991267, "min": 0.78504}, "location": {"width": 747, "top": 355, "height": 42, "left": 81}, "words": "使后两者血药浓度减低,故本品不宜与咪唑类合用。7.肾上腺皮质激素(糖皮质激"}, {"probability": {"variance": 7.8e-05, "average": 0.997819, "min": 0.945745}, "location": {"width": 744, "top": 379, "height": 41, "left": 85}, "words": "素、盐皮质激素)、抗凝药、氨茶碱、茶碱、氯霉素、氯贝丁酯、环胞素、维拉帕"}, {"probability": {"variance": 8.5e-05, "average": 0.996695, "min": 0.946052}, "location": {"width": 747, "top": 401, "height": 41, "left": 84}, "words": "米(异搏定)、妥卡尼、普罗帕酮、甲氧苄啶、香豆素或茚满二酮衍生物、口服降"}, {"probability": {"variance": 1e-05, "average": 0.998321, "min": 0.982437}, "location": {"width": 747, "top": 423, "height": 41, "left": 83}, "words": "血糖药、促皮质素、氨苯砜、洋地黄苷类、丙吡胺、奎尼丁等与利福平合用时,由"}, {"probability": {"variance": 8.2e-05, "average": 0.996441, "min": 0.94933}, "location": {"width": 732, "top": 445, "height": 42, "left": 84}, "words": "于后者诱导肝微粒体酶活性,可使上述药物的药效减弱,因此除地高辛和氨苯砜外"}, {"probability": {"variance": 1.1e-05, "average": 0.998285, "min": 0.98295}, "location": {"width": 743, "top": 469, "height": 39, "left": 86}, "words": "在用利福平前和疗程中上述药物需调整剂量。本品与香豆素或茚满二酮类合用时应"}, {"probability": {"variance": 0.002339, "average": 0.990797, "min": 0.700806}, "location": {"width": 742, "top": 490, "height": 42, "left": 86}, "words": "每日或定期测定凝血酶原时间,据以调整剂量。8.本品可促进雌激素的代谢或减少"}, {"probability": {"variance": 2e-06, "average": 0.998829, "min": 0.993842}, "location": {"width": 746, "top": 514, "height": 41, "left": 85}, "words": "其肠肝循环,降低口服避孕药的作用,导致月经不规则,月经间期出血和计划外妊"}, {"probability": {"variance": 0.000187, "average": 0.996053, "min": 0.917962}, "location": {"width": 725, "top": 534, "height": 42, "left": 85}, "words": "娠。所以,患者服用利福平时,应改用其他避孕方法。9本品可诱导肝微粒体酶"}, {"probability": {"variance": 2e-06, "average": 0.999037, "min": 0.994651}, "location": {"width": 205, "top": 571, "height": 25, "left": 86}, "words": "增加抗肿瘤药达卡巴嗪"}, {"probability": {"variance": 8e-06, "average": 0.998535, "min": 0.990047}, "location": {"width": 379, "top": 560, "height": 27, "left": 451}, "words": "环磷酰胺的代谢,形成烷化代谢物,促使"}, {"probability": {"variance": 0.001895, "average": 0.98739, "min": 0.734975}, "location": {"width": 734, "top": 581, "height": 42, "left": 86}, "words": "白细胞减低,因此需调整剂量。10.本品与地西泮(安定)合用可增加后者的消除"}, {"probability": {"variance": 0.001979, "average": 0.989262, "min": 0.72385}, "location": {"width": 748, "top": 604, "height": 40, "left": 85}, "words": "使其血药浓度减低,故需调整剂量。11.本品可增加苯妥因在肝脏中的代谢,故两者"}, {"probability": {"variance": 0.002676, "average": 0.986957, "min": 0.733939}, "location": {"width": 746, "top": 627, "height": 39, "left": 86}, "words": "合用时应测定苯妥因血药浓度并调整用量。12.本品可增加左旋甲状腺素在肝脏中的"}, {"probability": {"variance": 0.000107, "average": 0.995545, "min": 0.947006}, "location": {"width": 747, "top": 646, "height": 42, "left": 85}, "words": "降解、因此两者合用时左旋甲状腺素剂量应增加。13.本品亦可增加美沙酮、美西律"}, {"probability": {"variance": 1.3e-05, "average": 0.998376, "min": 0.979378}, "location": {"width": 747, "top": 672, "height": 39, "left": 86}, "words": "在肝脏中的代谢,引起美沙酮撤药症状和美西律血药浓度减低,故合用时后两者需"}, {"probability": {"variance": 0.001883, "average": 0.989873, "min": 0.728216}, "location": {"width": 750, "top": 694, "height": 37, "left": 86}, "words": "调整剂量。14.丙磺舒可与本品竞争被肝细胞的摄入,使本品血药浓度增高并产生毒"}, {"probability": {"variance": 7e-06, "average": 0.998376, "min": 0.990525}, "location": {"width": 663, "top": 718, "height": 38, "left": 86}, "words": "性反应。但该作用不稳定,故通常不宜加用丙磺舒以增高本品的血药浓度"}, {"probability": {"variance": 1e-06, "average": 0.999109, "min": 0.99705}, "location": {"width": 84, "top": 752, "height": 23, "left": 141}, "words": "药物过量"}, {"probability": {"variance": 4e-06, "average": 0.998249, "min": 0.991754}, "location": {"width": 557, "top": 738, "height": 37, "left": 274}, "words": "逾量的表现:精神迟钝;眼周或面部水肿;全身瘙痒;红人综"}, {"probability": {"variance": 3.8e-05, "average": 0.99718, "min": 0.966907}, "location": {"width": 743, "top": 759, "height": 42, "left": 88}, "words": "合征(皮肤粘膜及巩膜呈红色或橙色)。有原发肝病,酗酒者或同服其他肝毒性药"}, {"probability": {"variance": 0.001918, "average": 0.986324, "min": 0.834727}, "location": {"width": 249, "top": 795, "height": 24, "left": 88}, "words": "物者可能引起死亡。2.处理"}, {"probability": {"variance": 0.00027, "average": 0.993602, "min": 0.923952}, "location": {"width": 426, "top": 789, "height": 24, "left": 390}, "words": "停药。(2)洗胃,因患者往往出现恶心、呕吐"}, {"probability": {"variance": 7e-06, "average": 0.998504, "min": 0.98673}, "location": {"width": 745, "top": 805, "height": 42, "left": 88}, "words": "不宜再催吐;洗胃后给予活性炭糊,以吸收胃肠道内残余的利福平;有严重恶心呕"}, {"probability": {"variance": 0.000192, "average": 0.99541, "min": 0.92353}, "location": {"width": 595, "top": 831, "height": 37, "left": 86}, "words": "吐者给予止吐剂。(3)静脉输液并给予利尿剂,促进药物的排泄"}, {"probability": {"variance": 0.008998, "average": 0.955009, "min": 0.742972}, "location": {"width": 108, "top": 832, "height": 22, "left": 728}, "words": "1)对症和支"}, {"probability": {"variance": 0.000464, "average": 0.97936, "min": 0.949459}, "location": {"width": 61, "top": 866, "height": 23, "left": 90}, "words": "持疗法"}, {"probability": {"variance": 0.000994, "average": 0.991821, "min": 0.814726}, "location": {"width": 689, "top": 872, "height": 41, "left": 147}, "words": "药理毒理】利福平为利福霉素类半合成广谱抗菌药,对多种病原微生物均有"}, {"probability": {"variance": 4e-05, "average": 0.996971, "min": 0.964713}, "location": {"width": 746, "top": 896, "height": 38, "left": 88}, "words": "抗菌活性。该药对结核分枝杆菌和部分非结核分枝杆菌(包括麻风分枝杆菌等)在"}, {"probability": {"variance": 1e-06, "average": 0.999146, "min": 0.994237}, "location": {"width": 749, "top": 919, "height": 43, "left": 86}, "words": "宿主细胞内外均有明显的杀菌作用。利福平对需氧革兰阳性菌具良好抗菌作用,包"}, {"probability": {"variance": 9e-06, "average": 0.998226, "min": 0.984533}, "location": {"width": 754, "top": 940, "height": 43, "left": 83}, "words": "括葡萄球菌产酶株及甲氧西林耐药株、肺炎链球菌、其他链球菌属、肠球菌属、李"}, {"probability": {"variance": 5.3e-05, "average": 0.996462, "min": 0.960127}, "location": {"width": 751, "top": 962, "height": 41, "left": 87}, "words": "斯特菌属、炭疽杆菌、产气荚膜杆菌、白喉杆菌、厌氧球菌等。对需氧革兰阴性菌如"}, {"probability": {"variance": 5e-06, "average": 0.998281, "min": 0.990641}, "location": {"width": 746, "top": 986, "height": 39, "left": 90}, "words": "脑膜炎奈瑟球菌、流感嗜血杆菌、淋病奈瑟球菌亦具高度抗菌活性。利福平对军团"}, {"probability": {"variance": 2e-05, "average": 0.997735, "min": 0.975583}, "location": {"width": 735, "top": 1009, "height": 39, "left": 90}, "words": "菌属作用亦良好,对沙眼衣原体、性病淋巴肉芽肿及鹦鹉热等病原体均具抑制作用"}, {"probability": {"variance": 0.001835, "average": 0.991032, "min": 0.738063}, "location": {"width": 704, "top": 1029, "height": 42, "left": 130}, "words": "细菌对利福霉素类抗生素有交叉耐药。利福平与依赖DNA的RNA多聚酶的B亚"}, {"probability": {"variance": 3.2e-05, "average": 0.997007, "min": 0.976391}, "location": {"width": 743, "top": 1052, "height": 40, "left": 90}, "words": "单位牢固结合,抑制细菌RNA的合成,防止该酶与DNA连接,从而阻断RNA转录过"}, {"probability": {"variance": 5e-06, "average": 0.998033, "min": 0.992798}, "location": {"width": 264, "top": 1084, "height": 31, "left": 91}, "words": "程,使DNA和蛋白的合成停止"}, {"probability": {"variance": 0.000424, "average": 0.992488, "min": 0.899922}, "location": {"width": 693, "top": 1096, "height": 43, "left": 143}, "words": "药代动力学】利福平口服吸收良好,服药后1.5~4小时血药浓度达峰值。成人"}, {"probability": {"variance": 0.000598, "average": 0.989792, "min": 0.870081}, "location": {"width": 725, "top": 1124, "height": 37, "left": 110}, "words": "次口服600mg后血药峰浓度(Cmax)为7~9mg/L,6个月至5岁小儿一次口服10mg/kg"}, {"probability": {"variance": 0.008105, "average": 0.97235, "min": 0.575172}, "location": {"width": 726, "top": 1147, "height": 36, "left": 87}, "words": "血药峰浓度(Cmax)为1lmg/L。本品在大部分组织和体液中分布良好,包括脑脊液"}, {"probability": {"variance": 0.002726, "average": 0.986659, "min": 0.728773}, "location": {"width": 738, "top": 1164, "height": 42, "left": 101}, "words": "当脑膜有炎症时脑脊液内药物浓度增加;在唾液中亦可达有效治疗浓度;本品可穿"}, {"probability": {"variance": 0.005141, "average": 0.973904, "min": 0.625568}, "location": {"width": 743, "top": 1189, "height": 38, "left": 91}, "words": "过胎盘。表观分布容积(Vd)为1.6L/kg。蛋白结合率为80%~91%。进食后服药可"}, {"probability": {"variance": 0.017889, "average": 0.950853, "min": 0.381367}, "location": {"width": 740, "top": 1209, "height": 42, "left": 93}, "words": "使药物的吸收减少30%,该药的血消除半衰期(t2B)为3-5小时,多次给药后有所"}, {"probability": {"variance": 0.001867, "average": 0.987327, "min": 0.79778}, "location": {"width": 738, "top": 1233, "height": 43, "left": 90}, "words": "缩短,为2~3小时。本品在肝脏中可被自身诱导微粒体氧化酶的作用而迅速去乙酰化"}, {"probability": {"variance": 6e-06, "average": 0.997992, "min": 0.989277}, "location": {"width": 722, "top": 1255, "height": 40, "left": 92}, "words": "成为具有抗菌活性的代谢物去乙酰利福平,水解后形成无活性的代谢物由尿排出"}, {"probability": {"variance": 1e-06, "average": 0.999301, "min": 0.994916}, "location": {"width": 708, "top": 1276, "height": 41, "left": 129}, "words": "本品主要经胆和肠道排泄,可进入肠肝循环,但其去乙酰活性代谢物则无肠肝"}, {"probability": {"variance": 1.1e-05, "average": 0.997974, "min": 0.980212}, "location": {"width": 748, "top": 1300, "height": 40, "left": 92}, "words": "循环。60%~65%的给药量经粪便排出,6%~15%的药物以原形、15%以活性代谢物"}, {"probability": {"variance": 2e-06, "average": 0.998552, "min": 0.997021}, "location": {"width": 85, "top": 1333, "height": 25, "left": 94}, "words": "经尿排出"}, {"probability": {"variance": 0.010273, "average": 0.97978, "min": 0.424749}, "location": {"width": 620, "top": 1321, "height": 39, "left": 219}, "words": "%则以无活性的3甲酰衍生物排出。亦可经乳汁排出。肾功能减退的"}, {"probability": {"variance": 3.1e-05, "average": 0.998012, "min": 0.966124}, "location": {"width": 750, "top": 1344, "height": 44, "left": 91}, "words": "患者中本品无积聚;由于自身诱导肝微粒体氧化酶的作用,在服用利福平的6~10天"}, {"probability": {"variance": 0.001081, "average": 0.993281, "min": 0.799343}, "location": {"width": 748, "top": 1368, "height": 39, "left": 93}, "words": "后其排泄率增加;用高剂量后由于胆道排泄达到饱和,本品的排泄可能延缓。利福"}, {"probability": {"variance": 3.4e-05, "average": 0.997211, "min": 0.976632}, "location": {"width": 309, "top": 1398, "height": 32, "left": 95}, "words": "平不能经血液透析或腹膜透析清除"}, {"probability": {"variance": 5e-06, "average": 0.998288, "min": 0.990083}, "location": {"width": 502, "top": 1416, "height": 35, "left": 148}, "words": "贮藏】密封,在阴暗(避光并不超过20℃)干燥处保存"}, {"probability": {"variance": 0.001615, "average": 0.985433, "min": 0.831745}, "location": {"width": 496, "top": 1441, "height": 32, "left": 149}, "words": "包装】铝塑包装,10粒×10板/盒;塑料瓶装,100粒/瓶"}, {"probability": {"variance": 5e-06, "average": 0.99815, "min": 0.993573}, "location": {"width": 149, "top": 1470, "height": 27, "left": 149}, "words": "有效期】24个月"}, {"probability": {"variance": 0.002089, "average": 0.987372, "min": 0.794073}, "location": {"width": 366, "top": 1488, "height": 35, "left": 147}, "words": "执行标准】《中国药典》2005年版二部"}, {"probability": {"variance": 0.000368, "average": 0.991936, "min": 0.931824}, "location": {"width": 216, "top": 1512, "height": 29, "left": 149}, "words": "批准文号】国药准字H3"}, {"probability": {"variance": 0.029026, "average": 0.937653, "min": 0.408376}, "location": {"width": 548, "top": 1546, "height": 53, "left": 189}, "words": "△浙江医药股份有限公司新昌制药厂"}, {"probability": {"variance": 0.000918, "average": 0.988654, "min": 0.845533}, "location": {"width": 539, "top": 1590, "height": 41, "left": 98}, "words": "生产地址浙江省新昌县城关镇新昌大道东路98号邮编312500"}, {"probability": {"variance": 0.002452, "average": 0.986371, "min": 0.707972}, "location": {"width": 433, "top": 1615, "height": 34, "left": 99}, "words": "电话:0575-86026388传真:0575-86026388网址"}, {"probability": {"variance": 0.021526, "average": 0.903496, "min": 0.512448}, "location": {"width": 95, "top": 1632, "height": 21, "left": 743}, "words": "SZJ060101"}], "language": -1}